The Needle Biopsy Market Size is expected to reach USD 24,421.3 Million by 2030 at 12.5% CAGR during the forecast period 2022-2030. The needle biopsy market is chiefly driven by product development and the fall in prices of raw materials and components. The increasing cases of cancers and growing usage of biopsy needles is driving the market. Companies should focus on improving the distribution efficiency so as to reduce the pressures on prices due to huge market fragmentation. Distributional agreements between large players and advanced products such as multilayer needles will be extremely beneficial. The emergence of needle biopsy is estimated to pose the greatest threat to the biopsy needle market. Needle biopsy offers non-invasive diagnostic tests for detecting cancer as it used liquids such as blood, urine, saliva etc. to detect malignancy. Increasing automation will enhance the capabilities of needle biopsy and it may substitute the needle biopsy procedures. Real time progression of cancers is also possible in needle biopsy which raises the level of threat it possess to needle biopsy. The falling cost of products due to greater market fragmentation and the emergence of Chinese companies is expected to put additional pressures on prices.
In our estimates vacuum assisted needle biopsy will be the fastest growing segment. The increasing screening rates for cancers through the world will stimulate the market. Among the various cancers, breast cancer is expected to generate the largest use of needle biopsy. Needle Based Biopsy Guns is another lucrative strategy that is being pursued by many players. Core needle biopsy has a higher efficiency and detectability rate than fine needle aspiration biopsy. There is increasing bias to use core needle biopsy in combination with needle aspiration biopsy to achieve highest sensitivity and detectability. Thus, the two tests are complementary, and the effectiveness rate is highest with both tests are done together.
Needle Biopsy Market Insights, Growth And Trends Analysis By Type (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy) Utility (Disposable, Reusable), Applications (Tumor, Infection, Inflammation, Others) - Forecast Till 2030
Major Key Players:
Some of the key Needle Biopsy Market players are Boston Scientific Corporation, Cook Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc., Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others
Segment Analysis
The global needle biopsy market is segmented on the basis of type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the market has been segmented as tumor, infection, inflammation and others.
Challenges and Future Prospects
Operator Skill and Training: Performing needle biopsy procedures requires a high level of skill and expertise. Ensuring that healthcare professionals receive adequate training is essential for maintaining the safety and efficacy of these procedures.
Sample Adequacy: In some cases, needle biopsy samples may not provide enough tissue for a conclusive diagnosis. Researchers are working on innovative solutions to overcome this challenge and improve the diagnostic yield.
Cost Implications: While needle biopsy procedures are generally more cost-effective than traditional surgeries, the initial investment in imaging equipment and specialized biopsy tools can be significant for healthcare facilities.
Integration of Artificial Intelligence (AI): The integration of AI and machine learning algorithms holds the potential to revolutionize the needle biopsy process. AI can assist in real-time image analysis, improving the accuracy of needle placement and enhancing diagnostic outcomes.
Personalized Medicine and Biomarker Discovery: Needle biopsy samples offer a valuable resource for biomarker discovery and personalized medicine initiatives. As our understanding of disease genetics and molecular profiles grows, needle biopsy could play a central role in tailoring treatments to individual patients.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
